Literature DB >> 30202329

The Current Understanding of Sarcopenia: Emerging Tools and Interventional Possibilities.

Matthew J Delmonico1, Darren T Beck1.   

Abstract

The purpose of this review is to provide health practitioners and physicians the most current state of the research on sarcopenia, its consequences, and to offer a summary of consensus guidelines for identification based on the most recent and compelling investigations and analyses. To accomplish this, the causes and consequences of sarcopenia will be described, and definitions and screening methods are updated. Importantly, interventional recommendations for sarcopenia will be discussed with a special emphasis on the effects of resistance training on sarcopenia-related outcomes. Furthermore, due to the increasing usage of hormone treatment as a strategy to combat sarcopenia, special consideration on the effects of hormone changes with aging and as interventions will be briefly reviewed.

Entities:  

Keywords:  aging; function; muscle; strength

Year:  2016        PMID: 30202329      PMCID: PMC6125026          DOI: 10.1177/1559827615594343

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  158 in total

1.  Velocity training induces power-specific adaptations in highly functioning older adults.

Authors:  D R Earles; J O Judge; O T Gunnarsson
Journal:  Arch Phys Med Rehabil       Date:  2001-07       Impact factor: 3.966

Review 2.  Optimal protein intake in the elderly.

Authors:  Robert R Wolfe; Sharon L Miller; Kevin B Miller
Journal:  Clin Nutr       Date:  2008-09-25       Impact factor: 7.324

3.  Coimpairments: strength and balance as predictors of severe walking disability.

Authors:  T Rantanen; J M Guralnik; L Ferrucci; S Leveille; L P Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-04       Impact factor: 6.053

4.  DHEA in elderly women and DHEA or testosterone in elderly men.

Authors:  K Sreekumaran Nair; Robert A Rizza; Peter O'Brien; Ketan Dhatariya; Kevin R Short; Ajay Nehra; Janet L Vittone; George G Klee; Ananda Basu; Rita Basu; Claudio Cobelli; Gianna Toffolo; Chiara Dalla Man; Donald J Tindall; L Joseph Melton; Glenn E Smith; Sundeep Khosla; Michael D Jensen
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

5.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

6.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

7.  Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.

Authors:  Michele Iannuzzi-Sucich; Karen M Prestwood; Anne M Kenny
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-12       Impact factor: 6.053

8.  Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

Authors:  Stephanie T Page; John K Amory; F Dubois Bowman; Bradley D Anawalt; Alvin M Matsumoto; William J Bremner; J Lisa Tenover
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

9.  ACE I/D and ACTN3 R/X polymorphisms as potential factors in modulating exercise-related phenotypes in older women in response to a muscle power training stimuli.

Authors:  Ana Pereira; Aldo M Costa; Mikel Izquierdo; António J Silva; Estela Bastos; Mário C Marques
Journal:  Age (Dordr)       Date:  2012-08-02

10.  An evidence-based comparison of operational criteria for the presence of sarcopenia.

Authors:  Thuy-Tien Dam; Katherine W Peters; Maren Fragala; Peggy M Cawthon; Tamara B Harris; Robert McLean; Michelle Shardell; Dawn E Alley; Anne Kenny; Luigi Ferrucci; Jack Guralnik; Douglas P Kiel; Steve Kritchevsky; Maria T Vassileva; Stephanie Studenski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more
  7 in total

1.  Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.

Authors:  Gabriel F P Aleixo; Shlomit S Shachar; Kirsten A Nyrop; Hyman B Muss; Claudio L Battaglini; Grant R Williams
Journal:  Oncologist       Date:  2019-11-12

2.  Deep Learning-Based Muscle Segmentation and Quantification of Full-Leg Plain Radiograph for Sarcopenia Screening in Patients Undergoing Total Knee Arthroplasty.

Authors:  Doohyun Hwang; Sungho Ahn; Yong-Beom Park; Seong Hwan Kim; Hyuk-Soo Han; Myung Chul Lee; Du Hyun Ro
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

Review 3.  Getting to grips with sarcopenia: recent advances and practical management for the gastroenterologist.

Authors:  Thomas William Hollingworth; Siddhartha M Oke; Harnish Patel; Trevor R Smith
Journal:  Frontline Gastroenterol       Date:  2020-01-20

4.  Influence of sarcopenia focused on critically ill patients.

Authors:  Belgin Akan
Journal:  Acute Crit Care       Date:  2021-02-02

5.  Low muscle mass is an independent risk factor for postoperative blood transfusion in total knee arthroplasty: a retrospective, propensity score-matched cohort study.

Authors:  Doohyun Hwang; Hyuk-Soo Han; Myung Chul Lee; Du Hyun Ro
Journal:  BMC Geriatr       Date:  2022-03-17       Impact factor: 3.921

6.  An analysis study of sarcopenia and locomotive syndrome in the old people using evaluation tool.

Authors:  Myung-Chul Kim; Hang-Sik Park; Hae-In Kim; Jean-Kyung Paik; Dong-Kun Chung
Journal:  J Exerc Rehabil       Date:  2022-08-26

Review 7.  Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.

Authors:  Gabriel F P Aleixo; Shlomit S Shachar; Kirsten A Nyrop; Hyman B Muss; Claudio L Battaglini; Grant R Williams
Journal:  Oncologist       Date:  2019-11-12       Impact factor: 5.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.